Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Chinese Patent Office
Teva
US Army
McKinsey
Queensland Health

Generated: May 22, 2019

DrugPatentWatch Database Preview

MIGALASTAT HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic sources for migalastat hydrochloride and what is the scope of migalastat hydrochloride freedom to operate?

Migalastat hydrochloride is the generic ingredient in one branded drug marketed by Amicus Theraps Us and is included in one NDA. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Migalastat hydrochloride has eighty-six patent family members in twenty-four countries.

One supplier is listed for this compound.

Summary for MIGALASTAT HYDROCHLORIDE
International Patents:86
US Patents:7
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 28
Clinical Trials: 14
Patent Applications: 3
DailyMed Link:MIGALASTAT HYDROCHLORIDE at DailyMed
Synonyms for MIGALASTAT HYDROCHLORIDE
(+)-(2R,3S,4R,5S)-2-(Hydroxymethyl)piperidine-3,4,5-triol hydrochloride
(2R,3S,4R,5S)-2-(hydroxymethyl)-3,4,5-Piperidinetriol hydrochloride
(2R,3S,4R,5S)-2-(Hydroxymethyl)piperidine-3,4,5-triol hydrochloride
1-Deoxy-L-altronojirimycin Hydrochloride
1-Deoxygalactonojirimycin HCl
1-Deoxynojirimycin hydrochloride
1,5-Dideoxy-1,5-imino-D-galactitol
1,5-dideoxy-1,5-imino-d-galactitol hydrochloride
3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, hydrochloride, (2R,3S,4R,5S)-
75172-81-5
AKOS027384247
Amigal
BICL4269
CHEMBL2107355
CLY7M0XD20
CS-6380
D05031
Deoxygalactonojirimycin hydrochloride
Deoxygalactonojirimycin, Hydrochloride
DEOXYGALACTONOJIRIMYCIN,HYDROCHLORIDE
FT-0665818
Galafold (TN)
HY-14929A
KB-270793
Migalastat (hydrochloride)
migalastat HCl
Migalastat hydrochloride (JAN/USAN)
Migalastat Hydrochloride [USAN]
MolPort-039-016-078
OR2365T
SCHEMBL3802618
UNII-CLY7M0XD20
W-203722
ZX-AT009958

US Patents and Regulatory Information for MIGALASTAT HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amicus Theraps Us GALAFOLD migalastat hydrochloride CAPSULE;ORAL 208623-001 Aug 10, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amicus Theraps Us GALAFOLD migalastat hydrochloride CAPSULE;ORAL 208623-001 Aug 10, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amicus Theraps Us GALAFOLD migalastat hydrochloride CAPSULE;ORAL 208623-001 Aug 10, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amicus Theraps Us GALAFOLD migalastat hydrochloride CAPSULE;ORAL 208623-001 Aug 10, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for MIGALASTAT HYDROCHLORIDE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2787345 CR 2016 00055 Denmark ➤ Sign Up PRODUCT NAME: MIGALASTAT ELLER ET SALT HERAF, HERUNDER HYDROGENKLORIDSALTET; REG. NO/DATE: EU/1/15/1082 20160531
2787345 PA2016033,C2787345 Lithuania ➤ Sign Up PRODUCT NAME: MIGALASTATAS ARBA JO DRUSKA, ISKAITANT IR HIDROCHLORIDO DRUSKA; REGISTRATION NO/DATE: EU/1/15/1082 20160526
2787345 93312 Luxembourg ➤ Sign Up PRODUCT NAME: MIGALASTAT OU UN SEL DE CELUI-CI , Y COMPRIS LE SEL DE CHLORHYDRATE; AUTHORISATION NUMBER AND DATE: EU/1/15/1082 - GALAFOLD - MIGALASTAT
2787345 268 5025-2016 Slovakia ➤ Sign Up PRODUCT NAME: MIGALASTAT VO VSETKYCH FORMACH CHRANENYCH ZAKLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/15/1082 20160531
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Daiichi Sankyo
Julphar
Queensland Health
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.